Wen Wu

1.5k total citations
29 papers, 1.2k citations indexed

About

Wen Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wen Wu has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Wen Wu's work include Sulfur Compounds in Biology (4 papers), Cancer-related molecular mechanisms research (4 papers) and Advanced Glycation End Products research (4 papers). Wen Wu is often cited by papers focused on Sulfur Compounds in Biology (4 papers), Cancer-related molecular mechanisms research (4 papers) and Advanced Glycation End Products research (4 papers). Wen Wu collaborates with scholars based in China, United States and South Korea. Wen Wu's co-authors include M. Alan Permutt, Ernesto Bernal‐Mizrachi, Cris M. Welling, Jianqiang Feng, Harold A. Singer, Xiaochun Long, Wenming Xu, Wei Zhang, Jinjing Zhao and David Jourd’heuil and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and Oncogene.

In The Last Decade

Wen Wu

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Wu China 16 705 576 248 198 150 29 1.2k
Judith Magenheim Israel 15 704 1.0× 544 0.9× 302 1.2× 182 0.9× 202 1.3× 24 1.3k
Béatrice Jaspard‐Vinassa France 24 631 0.9× 307 0.5× 89 0.4× 238 1.2× 135 0.9× 35 1.3k
Alba Casellas Spain 20 569 0.8× 560 1.0× 352 1.4× 360 1.8× 73 0.5× 30 1.3k
James K. Oeser United States 19 618 0.9× 476 0.8× 387 1.6× 190 1.0× 60 0.4× 40 1.1k
Pili Zhang United States 18 637 0.9× 626 1.1× 335 1.4× 362 1.8× 97 0.6× 22 1.5k
Jennifer Oliver‐Krasinski United States 12 568 0.8× 787 1.4× 421 1.7× 300 1.5× 45 0.3× 18 1.5k
Esa Tahvanainen Finland 24 465 0.7× 337 0.6× 475 1.9× 397 2.0× 111 0.7× 36 1.5k
Shigeru Yatoh Japan 25 793 1.1× 705 1.2× 266 1.1× 421 2.1× 263 1.8× 44 1.7k
Bardia Askari United States 15 802 1.1× 208 0.4× 106 0.4× 105 0.5× 134 0.9× 20 1.3k
Kaku Tsuruzoe Japan 19 652 0.9× 361 0.6× 137 0.6× 273 1.4× 94 0.6× 29 1.1k

Countries citing papers authored by Wen Wu

Since Specialization
Citations

This map shows the geographic impact of Wen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Wu more than expected).

Fields of papers citing papers by Wen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Wu. The network helps show where Wen Wu may publish in the future.

Co-authorship network of co-authors of Wen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Wu. A scholar is included among the top collaborators of Wen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Wu. Wen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Wen, et al.. (2025). Deubiquitinase USP28 promotes the malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 9251–9265. 1 indexed citations
3.
Shi, Cong, Shixiang Bao, Jinli Gong, et al.. (2025). Integrated genomic and transcriptomic analysis reveals the mechanisms underlying leaf variegation in ‘Gonggan’ mandarin. BMC Plant Biology. 25(1). 472–472. 1 indexed citations
4.
Wu, Wen, et al.. (2023). Advances in time-modulated phased array technology. Chinese Science Bulletin (Chinese Version). 69(3). 414–430. 1 indexed citations
5.
Chen, Jingjing, Xiao‐Long Jiang, Xin Gao, et al.. (2023). Ferroptosis-related genes as diagnostic markers for major depressive disorder and their correlations with immune infiltration. Frontiers in Medicine. 10. 1215180–1215180. 8 indexed citations
6.
Wu, Wen, et al.. (2022). Circ_0061395 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1182 sponge. Cell Cycle. 21(20). 2192–2205. 6 indexed citations
7.
8.
Li, Ping, Jian Wang, Desheng Wu, et al.. (2019). <p>ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes</p>. Cancer Management and Research. Volume 11. 8111–8123. 9 indexed citations
9.
Xia, Weibo, Zhenlin Zhang, Wen Wu, et al.. (2019). Prevalence of Vitamin D Inadequacy Among Chinese Postmenopausal Women: A Nationwide, Multicenter, Cross-Sectional Study. Frontiers in Endocrinology. 9. 782–782. 27 indexed citations
10.
Wu, Wen, Wei Zhang, Mihyun Choi, et al.. (2019). Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation. Redox Biology. 22. 101137–101137. 51 indexed citations
11.
Gao, Ping, Wen Wu, Yao Wei Lu, et al.. (2018). Transforming growth factor β1 suppresses proinflammatory gene program independent of its regulation on vascular smooth muscle differentiation and autophagy. Cellular Signalling. 50. 160–170. 17 indexed citations
12.
Liu, Yi, Haijuan Liu, Mei Li, et al.. (2014). Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis. Chinese Medical Journal. 127(4). 662–668. 11 indexed citations
13.
Xu, Wenming, Jingfu Chen, Donghong Liu, et al.. (2014). Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways. International Journal of Molecular Medicine. 35(1). 177–186. 48 indexed citations
14.
Xu, Wenming, Wen Wu, Jingfu Chen, et al.. (2013). Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways. International Journal of Molecular Medicine. 32(4). 917–925. 51 indexed citations
15.
Hu, Yanting, et al.. (2012). Genetic association of UBE2B variants with susceptibility to male infertility in a Northeast Chinese population. Genetics and Molecular Research. 11(4). 4226–4234. 7 indexed citations
16.
Wu, Keng, et al.. (2012). Increased expression of heat shock protein 90 under chemical hypoxic conditions protects cardiomyocytes against injury induced by serum and glucose deprivation. International Journal of Molecular Medicine. 30(5). 1138–1144. 18 indexed citations
17.
18.
Lü, Yan, et al.. (2009). Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene. 29(7). 1041–1049. 22 indexed citations
19.
Bernal‐Mizrachi, Ernesto, et al.. (2001). Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia. Journal of Clinical Investigation. 108(11). 1631–1638. 324 indexed citations
20.
Bernal‐Mizrachi, Ernesto, et al.. (2001). Activation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells. American Journal of Physiology-Endocrinology and Metabolism. 281(6). E1286–E1299. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith Magenheim Breakdown of academic impact, for papers by Béatrice Jaspard‐Vinassa Breakdown of academic impact, for papers by Alba Casellas Breakdown of academic impact, for papers by James K. Oeser Breakdown of academic impact, for papers by Pili Zhang Breakdown of academic impact, for papers by Jennifer Oliver‐Krasinski Breakdown of academic impact, for papers by Esa Tahvanainen Breakdown of academic impact, for papers by Shigeru Yatoh Breakdown of academic impact, for papers by Bardia Askari Breakdown of academic impact, for papers by Kaku Tsuruzoe
Rankless by CCL
2026